Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Emphysema or COPD: early-phase trial registry

6 of 8 indexed Emphysema or COPD trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 6 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Emphysema or COPD: 8 US clinical trials tracked, 6 recruiting.

Emphysema or COPD is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Beth Israel Deaconess Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition emphysema-or-copd

OPEN 6 | RECR 75% | LATE 0 | EARLY 2 | RANK #2176 | SPON 2

Nearest open-share peer: Adolescent Idiopathic Scoliosis (75% recruiting · 8 trials)

Activity, Motor75%Emphysema or COPD (this)75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Emphysema or COPD

Emphysema or COPD lists 6 open slots (75% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Emphysema or COPD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Emphysema or COPD is recruiting above its size-band peers.

    6 of 8 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Emphysema or COPD research.

    Beth Israel Deaconess Medical Center accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Emphysema or COPD trials plan to enrol fewer than 100 people.

    Median target enrolment is 63 among the 8 trials that report a genuine target (sentinel values excluded). 6 of those (75%) plan for fewer than 100 participants.

  4. Emphysema or COPD research is mostly interventional.

    6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Emphysema or COPD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Alvelestat (MPH966) Drug
1 trials
Endobronchial valves placement Device
1 trials
Robotic or VATS lobar fissure completion Procedure
1 trials
Interlobar fissure completion and pleural adhesiolysis Procedure
1 trials
CD3/CD19 negative hematopoietic stem cells Biological
1 trials
Telehealth Maintenance Exercise Combination
1 trials
Onsite Maintenance Exercise Training Combination
1 trials
AeriSeal System Device
1 trials

US sites by state

Facility locations filed on Emphysema or COPD trials. A trial with sites in several states counts in each.

Massachusetts 5 trials
Pennsylvania 3 trials
Texas 2 trials
Ohio 2 trials
New York 2 trials
Illinois 2 trials
Colorado 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Emphysema or COPD page

8 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Emphysema or COPD condition card totals 8 registered trials; most-linked intervention Alvelestat (MPH966); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.